1/3 L-WAVE ENT 19/2019 14 August 2019 Subject : Management’s Discussion and Analysis for the six-month period ending 30 June 2019 operating results that varied more than 20% compared to the same
Q1/ 2017 to 33.5% in Q1/2018; 2. Whilst SG&A including Interest expenses was up 10% Y-O-Y or Baht 17.7 million because of higher variables expenses that varied to company better performance, and non
together with a rise in revenues from sales of wellness and anti-aging Business Unit at Baht 128.58 million or increase of Baht 34.12 million or 26.54% in 2019 largely from sales of probiotic products such
livestock animal products, together with a rise in revenues from sales of healthcare products and aesthetic innovation products for human from Baht 224.58 million in 2018 to Baht 229.87 million or 2.36% in
livestock animal products, together with a rise in revenues from sales of healthcare products and aesthetic innovation products for human from Baht 224.58 million in 2018 to Baht 229.87 million or 2.36% in
, accounting and finance system, IT system, water and cleaning services (fees are varied by actual consumption). Pricing Criteria: Fee is calculated from cost of system and personnel plus margin, which is
services and other services in relation to HR system, accounting and finance system, IT system, waste water treatment and cleaning services (fees are varied by actual consumption). Pricing Criteria: Fee is
, accounting and finance system, IT system, water and cleaning services (fees are varied by actual consumption). Pricing Criteria: Fee is calculated from cost of system and personnel plus margin, which is
31.5% in the corresponding period last year. the rise in gross profits were achieved by both sale growth and improved gross profit margins mentioned above. The improvement in gross profit margins were
at Baht 48.06 million, increase of Baht 10.26 million or 27.14% compared to the same period 2018, varied to the increased revenue from sales of land and houses as bellows. Description Q1/2019 Q1/2018